Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug)
Matsuda, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
1993
ISSN/ISBN: 0047-1852 PMID: 8283663 Document Number: 415723
Document emailed within 1 workday
Related Documents
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Marchant, B.G.; Timmis, A.D. 1993: Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation British Journal of Hospital Medicine 49(3): 186-190
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Ikeda, Y. 1992: Pharmacological aspects of a novel antiplatelet drug, E5510 Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 366-371
Ahmad, S. 1984: Drug interactions complicate antiplatelet therapy Geriatrics 39(5): 137
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Pangrazzi, J.; Gianese, F. 1987: Dermatan sulfate as a potential antithrombotic drug Haematologica 72(5): 459-464
Kuliczkowski, W.; Zembala, M.; Poloński, L.; Kaczmarski, J.; Gasior, M. 2008: Monitoring of antiplatelet drug effects--fashion or necessity? Kardiologia Polska 66(1): 119-124
Tsvetaeva, N.V.; Sokolova, M.A.; Semenova, E.A.; Kolodeĭ, S.V.; Vasil'ev, S.A.; Orel, E.B.; Vadinskaia, L.A.; Khoroshko, N.D. 2002: A new antiplatelet drug agrilin in treating patients with hyperthrombocytosis Terapevticheskii Arkhiv 74(8): 72-74
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Stiefehlhagen, P. 2013: Your patient needs an antithrombotic drug, 4: Recurrence prevention after thrombosis: how long and with what? MMW Fortschritte der Medizin 155 Spec no 1(1): 28
Guha, S.; Sardar, P.; Guha, P.; Roy, S.; Mookerjee, S.; Chakrabarti, P.; Deb, P.K.; Chaudhuri, U.; Deb, S.; Karmakar, R.; Dasgupta, A.K.; Lahiri, P. 2009: Dual antiplatelet drug resistance in patients with acute coronary syndrome Indian Heart Journal 61(1): 68-73
Nasu, M.; Shikano, K.; Miyamura, K.; Shinpo, H.; Morimoto, T.; Ohi, T.; Shomura, S.; Yamazaki, N.; Yada, I.; Kusagawa, M. 1983: Evaluation of antiplatelet drug therapy and replaced heart valves based on platelet functions Kyobu Geka. Japanese Journal of Thoracic Surgery 36(9): 701-705
Moyer, J.A.; Shah, J.; Nowakowski, K.; Martin, A.; McNicholas, A.; Muller, A.; Fernandez, F.B.; Ong, A.W. 2018: Does Antithrombotic Drug use Mandate Trauma Team Activation in Awake Geriatric Patients with Intracranial Hemorrhage? American Surgeon 84(7): 1180-1184
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686
Yu, J.; Zheng, M.-s.; Xiao, C.-n.; Zheng, X.-h. 2015: Gray relational analysis for the effect of nano-drug features on drug absorption Yao Xue Xue Bao 50(9): 1096-1100
Bresnahan, K.; Zuckerman, B.; Cabral, H. 1992: Psychosocial correlates of drug and heavy alcohol use among pregnant women at risk for drug use Obstetrics and Gynecology 80(6): 976-980